Search the webpage

Created by Jenni J. Hakkarainen on   July 20, 2016   in category: News

Acute cytotoxic effects of the pharmaceutical excipients benzalkonium chloride (BAC), macrogolglycerol hydroxystearate (MGHS40), polysorbate 80 (PS80) and marketed ophthalmic formulations (Lumigan(R), Monoprost(R), Taflotan(R), Travatan(R), Xalatan(R)) containing these excipients were tested.

Human corneal epithelial cell (HCE-T) viability was assessed by measuring the reduction of resazurin to highly fluorescent resorufin.

The study was fully funded by Experimentica Ltd.

Leave a Comment


Meet Us at ARVO 2018

Email to set up a One-on-One meeting ... Read More

Meet us at the 2018 Bio Asia International conference

Experimentica Ltd. co-sponsors the 2018 Bio Asia International conference, to be held in Tokyo, Japan, March 19-20, 2018 ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers to!